Evonik declares force majeure for amino acid product

Evonik declares force majeure for amino acid product

Stokerplusss | Bigstock

Company says COVID-19 outbreak caused manufacturer to shut down production in China

Evonik said its contract manufacturer had to shut down its production facilities in China, the epicenter of the COVID-19 outbreak. Production and shipping of ThreAMINO are affected, as are all of Evonik’s ThreAMINO customers, the company said in an email. Evonik, however, would not disclose the production rate for the product.